Dr Philip Small will play a critical role in helping to increase profitability and accelerate growth at AMRI, following his appointment as managing director of European operations.
Small, who joined the company as director of chemistry in November 2007, replaces Dr Michael Guaciaro, who returns to AMRI's headquarters in Albany, NY.
Small brings over 20 years of experience gained at leading combinatorial chemistry/drug discovery companies in addition to Tripos including scientific leadership positions at OSI Pharmaceuticals, Oxford Diversity/OAI and Unilever Research. He obtained his PhD in organic chemistry from the University of Wolverhampton in the UK.
